RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 97 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q1 2016. The put-call ratio across all filers is 4.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,145,000 | +60.8% | 127,700 | -3.7% | 0.00% | +100.0% |
| Q2 2016 | $712,000 | +27.8% | 132,600 | +5.7% | 0.00% | 0.0% |
| Q1 2016 | $557,000 | +6.3% | 125,400 | +24.5% | 0.00% | 0.0% |
| Q4 2015 | $524,000 | -14.0% | 100,700 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $609,000 | -54.8% | 100,700 | +18.1% | 0.00% | -33.3% |
| Q2 2015 | $1,347,000 | +64.5% | 85,300 | +13.3% | 0.00% | +50.0% |
| Q1 2015 | $819,000 | +7.1% | 75,300 | +3.6% | 0.00% | -33.3% |
| Q4 2014 | $765,000 | +9.8% | 72,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $697,000 | -17.0% | 72,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $840,000 | +15.5% | 72,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $727,000 | +2.3% | 72,700 | +33.2% | 0.00% | 0.0% |
| Q4 2013 | $711,000 | +5.0% | 54,600 | +20.5% | 0.00% | 0.0% |
| Q3 2013 | $677,000 | +59.7% | 45,300 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $424,000 | – | 45,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,000,000 | $32,200,000 | 3.11% |
| SV Health Investors, LLC | 888,132 | $4,085,000 | 3.05% |
| Sarissa Capital Management LP | 2,725,000 | $12,535,000 | 2.76% |
| GREAT POINT PARTNERS LLC | 1,346,344 | $6,193,000 | 2.22% |
| Virtus ETF Advisers LLC | 126,869 | $584,000 | 0.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,840,000 | 0.40% |
| TFS CAPITAL LLC | 459,546 | $2,114,000 | 0.30% |
| GLOBEFLEX CAPITAL L P | 238,239 | $1,096,000 | 0.29% |
| TURNER INVESTMENTS LLC | 161,100 | $741,000 | 0.20% |
| Birchview Capital, LP | 40,000 | $184,000 | 0.13% |